Elsevier

Neuroscience

Volume 154, Issue 3, 26 June 2008, Pages 1143-1153
Neuroscience

Systems neuroscience
Effect of age on kainate-induced seizure severity and cell death

https://doi.org/10.1016/j.neuroscience.2008.03.082Get rights and content

Abstract

While the onset and extent of epilepsy increases in the aged population, the reasons for this increased incidence remain unexplored. The present study used two inbred strains of mice (C57BL/6J and FVB/NJ) to address the genetic control of age-dependent neurodegeneration by building upon previous experiments that have identified phenotypic differences in susceptibility to hippocampal seizure-induced cell death. We determined if seizure induction and seizure-induced cell death are affected differentially in young adult, mature, and aged male C57BL/6J and FVB/NJ mice administered the excitotoxin, kainic acid. Dose response testing was performed in three to four groups of male mice from each strain. Following kainate injections, mice were scored for seizure activity and brains from mice in each age group were processed for light microscopic histopathologic evaluation 7 days following kainate administration to evaluate the severity of seizure-induced brain damage. Irrespective of the dose of kainate administered or the age group examined, resistant strains of mice (C57BL/6J) continued to be resistant to seizure-induced cell death. In contrast, aged animals of the FVB/NJ strain were more vulnerable to the induction of behavioral seizures and associated neuropathology after systemic injection of kainic acid than young or middle-aged mice. Results from these studies suggest that the age-related increased susceptibility to the neurotoxic effects of seizure induction and seizure-induced injury is regulated in a strain-dependent manner, similar to previous observations in young adult mice.

Section snippets

Animals

Young (2-month-old), middle-aged (12 months) and old (18 months) male C57BL/6J (B6) mice, obtained from the NIA aging colony, and FVB/NJ (FVB) mice, aged in-house, were used as animal subjects. Animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Southern California. Every effort was made to minimize the number of

Results

We have previously demonstrated that certain strains of mice are strongly resistant to seizure-induced excitotoxic cell death in spite of similar seizure severity (Schauwecker and Steward 1997, Schauwecker et al 2000, Schauwecker 2000, Schauwecker 2002a, Schauwecker 2002b). Here we asked whether: 1) age can act as a risk factor to increase the susceptibility of mice to kainate-induced behavioral seizures and seizure-induced hippocampal cell loss; and 2) genetic susceptibility to seizure-induced

Discussion

This study used the kainate chemoconvulsant model to determine whether age is a risk factor for kainate-induced seizures and seizure-induced cell death in middle-aged and aged mice in comparison with established outcomes in young adult mice that are differentially susceptible to kainate-induced cell death. As a first step toward addressing the mechanism regulating susceptibility differences, we wanted to determine whether the variable response to kainate seizure induction and excitotoxic injury

Conclusions

In summary, our findings demonstrate that seizure susceptibility in both strains increases with advancing age. Among FVB mice, seizure-induced cell death becomes more pronounced with advancing age, while C57BL/6 mice continue to be resistant to KA-induced cell death. Future studies will need to reveal the risk factors and mechanisms responsible for differential vulnerability to glutamate excitotoxicity between these two mouse strains and the interaction with age.

Besides differences in glutamate

Acknowledgments

This work was supported by NIH grant AG025508 to P.E.S. and by the Rose Hills Foundation Research Fellowship to C.S.B. The authors wish to thank Dr. Thomas H. McNeill for thoughtful comments on the manuscript.

References (98)

  • K. Eckles-Smith et al.

    Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression

    Mol Brain Res

    (2000)
  • G.T. Golden et al.

    Rat strain and age differences in kainic acid induced seizures

    Epilepsy Res

    (1995)
  • R.A. Gonzales et al.

    N-methyl-D-aspartate mediated responses decrease with age in F-344 rat brain

    Neurobiol Aging

    (1991)
  • A. Gutiérrez et al.

    Aging-related subunit expression changes of the GABAA receptor in the rat hippocampus

    Neuroscience

    (1996)
  • K.M. Kelly et al.

    Alterations in hippocampal voltage-gated calcium channel α1 subunit expression patterns after kainate-induced status epilepticus in aging rats

    Epilepsy Res

    (2003)
  • D.S. Kerr et al.

    Age-related changes in tolerance to the marine algal excitotoxin domoic acid

    Neuropharmacology

    (2002)
  • J.P. Kesslak et al.

    Vulnerability of the hippocampus to kainate excitotoxicity in the aged, mature and young adult rat

    Neuroscience Lett

    (1995)
  • W. Löscher

    Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugsA comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

    Epilepsy Res

    (2002)
  • W. Löscher

    Animal models of intractable epilepsy

    Prog Neurobiol

    (1997)
  • D.G. MacGregor et al.

    The attenuation of kainate-induced neurotoxicity by chromethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists

    Exp Neurol

    (1997)
  • C.A. Mejias-Aponte et al.

    Sex differences in models of temporal lobe epilepsy: role of testosterone

    Brain Res

    (2002)
  • E.K. Michaelis

    Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging

    Prog Neurobiol

    (1998)
  • J.J. Mitchell et al.

    Age-related changes in [3H]MK-801 binding in the Fischer 344 rat brain

    Neurobiol Aging

    (1998)
  • K. Morimoto et al.

    Kindling and status epilepticus models of epilepsy: rewiring the brain

    Prog Neurobiol

    (2004)
  • J.V. Nadler et al.

    Use of excitatory amino acids to make axon-sparing lesions of the hypothalamus

    Methods Enzymol

    (1983)
  • J.V. Nadler et al.

    Loss and reacquisition of hippocampal synapses after selective destruction of CA3-CA4 afferents with kainic acid

    Brain Res

    (1980)
  • D.G. Nicholls et al.

    Mitochondria and neuronal glutamate excitotoxicity

    Biochim Biophys Acta

    (1998)
  • M.M. Nicolle et al.

    In vitro autoradiography of ionotropic glutamate receptors in hippocampus and striatum of aged Long-Evans rats: relationship to spatial learning

    Neuroscience

    (1996)
  • C. Nitsch et al.

    Distant blood-brain barrier opening in subfields of the rat hippocampus after intrastriatal injections of kainic acid but not ibotenic acid

    Neurosci Lett

    (1986)
  • M.M. Okazaki et al.

    Protective effects of mossy fiber lesions against kainic acid-induced seizures and neuronal degeneration

    Neuroscience

    (1988)
  • J.W. Olney

    Excitatory transmitter neurotoxicity

    Neurobiol Aging

    (1994)
  • T.A. Pitler et al.

    Aging-related prolongation of calcium spike duration in rat hippocampal slice neurons

    Brain Res

    (1990)
  • A. Pittaluga et al.

    Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine

    Eur J Pharmacol

    (1993)
  • R.J. Racine

    Modification of seizure activity by electrical stimulationII. Motor seizure

    Electroencephalogr Clin Neurophysiol

    (1972)
  • M. Ramsden et al.

    Androgens modulate neuronal vulnerability to kainate lesion

    Neuroscience

    (2003)
  • P.E. Schauwecker

    Differences in ionotropic glutamate receptor subunit expression are not responsible for strain-dependent susceptibility to excitotoxin-induced injury

    Mol Brain Res

    (2003)
  • P.E. Schauwecker

    Modulation of cell death by mouse genotype: Differential vulnerability to excitatory amino acid-induced lesions

    Exp Neurol

    (2002)
  • P.E. Schauwecker

    Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background

    Brain Res

    (2000)
  • P.E. Schauwecker et al.

    Genetic dissection of the signals that induce synaptic reorganization

    Exp Neurol

    (2000)
  • L.C. Schmued et al.

    Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons

    Brain Res

    (2005)
  • J.E. Schwob et al.

    Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study

    Neuroscience

    (1980)
  • W.E. Sonntag et al.

    Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats

    Brain Res Bull

    (2000)
  • G. Sperk

    Kainic acid seizures in the rat

    Prog Neurobiol

    (1994)
  • G. Sperk et al.

    Neurochemical and histopathological changes

    Neuroscience

    (1983)
  • M. Tamaru et al.

    Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus

    Brain Res

    (1991)
  • S. Vigues et al.

    Regulation of calcium channel alpha (1A) subunit splice variant mRNAs in kainate-induced temporal lobe epilepsy

    Neurobiol Dis

    (1999)
  • H. Wallace et al.

    Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy

    Lancet

    (1998)
  • G.L. Wenk et al.

    Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat

    Brain Res

    (2000)
  • D.F. Wozniak et al.

    Age-related sensitivity to kainate neurotoxicity

    Exp Neurol

    (1991)
  • Cited by (39)

    • Behavioral and electrophysiological changes in female mice overexpressing ORAI1 in neurons

      2019, Biochimica et Biophysica Acta - Molecular Cell Research
    • Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures

      2016, Experimental Neurology
      Citation Excerpt :

      Notable concerns and questions still remain for the KA mouse model. Single, bolus doses of KA result in variable rates of mortality and SE induction (Hu et al., 1998; McCord et al., 2008). Additionally, bolus doses of KA do not typically produce hippocampal cell death in C57 mice, despite the induction of SE (Chang et al., 2012; McCord et al., 2008; Schauwecker, 2000, 2003; Schauwecker and Steward, 1997), but see (Chang et al., 2012; Lee et al., 2014).

    • Lack of influence of prion protein gene expression on kainate-induced seizures in mice: Studies using congenic, coisogenic and transgenic strains

      2013, Neuroscience
      Citation Excerpt :

      In order to assess the potential influence of gender, data were analyzed and presented separately for males and females. Because age is known to influence KA susceptibility in mice (McCord et al., 2008), Prnp+/+ and Prnp−/− adult mice of similar ages were compared. Naturally derived KA monohydrate, extracted from Digenea simplex (Sigma–Aldrich, K2389, Missouri) was dissolved in phosphate-buffered saline (pH 7.4) and administered intraperitoneally (i.p.) for induction of seizures.

    • Neuroprotection by urokinase plasminogen activator in the hippocampus

      2012, Neurobiology of Disease
      Citation Excerpt :

      Epileptic seizures were induced by injecting KA (35 or 40 mg/kg body weight in 0.8% normal saline; Cayman, Ann Arbor, MI, USA) into the peritoneum of 4–5-month-old mice. Seizure behaviors were assessed for 3 h after KA injection and recorded every 2 h thereafter using the behavioral severity classification described by McCord et al. (2008), with some modification. Severity was classified as follows: stage 1, staring with immobility or hyporesponsiveness; stage 2, head nodding, twitching, myoclonic jerk, and/or rigid posture; stage 3, rearing, forelimb clonus, and/or salivation around the mouth; stage 4, repetitive rearing and falling, and/or loss of posture and body balance; stage 5, status epilepticus and/or vigorous movements, such as jumping, circling, and rolling; and stage 6, death.

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text